Charles Schwab Investment Management Inc Codexis, Inc. Transaction History
Charles Schwab Investment Management Inc
- $557 Billion
- Q2 2025
A detailed history of Charles Schwab Investment Management Inc transactions in Codexis, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 250,726 shares of CDXS stock, worth $686,989. This represents 0.0% of its overall portfolio holdings.
Number of Shares
250,726
Previous 250,250
0.19%
Holding current value
$686,989
Previous $673,000
9.21%
% of portfolio
0.0%
Previous 0.0%
Shares
32 transactions
Others Institutions Holding CDXS
# of Institutions
130Shares Held
69MCall Options Held
25.8KPut Options Held
20K-
Opaleye Management Inc. Boston, MA12.6MShares$34.5 Million7.35% of portfolio
-
Casdin Capital, LLC New York, NY7.2MShares$19.7 Million2.46% of portfolio
-
Black Rock Inc. New York, NY6.79MShares$18.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.59MShares$12.6 Million0.0% of portfolio
-
Abrdn PLC4.2MShares$11.5 Million0.02% of portfolio
About CODEXIS, INC.
- Ticker CDXS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,494,100
- Market Cap $179M
- Description
- Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...